Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Transplant and Addiction Project (TAP) - 1
This study is currently recruiting participants.
Verified by National Institute on Drug Abuse (NIDA), October 2005
Sponsored by: National Institute on Drug Abuse (NIDA)
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00249652
  Purpose

The purpose of this study is to test a novel distance-based (telephone) intervention to help transplant candidates with current or recent substance abuse to stay "clean and sober" both prior and following transplant surgery.


Condition Intervention Phase
End Stage Liver Disease
End Stage Renal Disease
Substance-Related Disorders
Behavioral: Transplant and Addiction Program
Phase I
Phase II

MedlinePlus related topics: Liver Diseases
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Drug Treatment for Transplant Candidates

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Abstinence
  • improved behavioral health
  • morbidity and mortality
  • being listed for and receiving transplant

Secondary Outcome Measures:
  • Therapeutic alliance
  • acceptance of intervention

Estimated Enrollment: 0
Study Start Date: September 2003
Detailed Description:

Participants who need a liver or renal transplant and who are ineligible due to current or recent (past 6 months) alcohol and/or other drug abuse are being recruited from the transplant programs at St. Luke's-Roosevelt Hospital Center (renal), Columbia Presbyterian Hospital (renal/liver) and Virginia Commonwealth University Medical Center (liver). Baseline and follow-up computer-assisted assessments and structured clinical interviews along with collection of biological samples (urine, hair) will occur in the transplant clinics; however, phone counseling sessions originate at St. Luke's. Participants are randomly assigned to one of two treatments: (1) usual care (no phone counseling) or (2) usual care + counseling. The telephone counseling sessions are designed to help participants become motivated to remain abstinent and improve other health behaviors such as sleep or stress management.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • End stage liver or renal disease
  • Having used drugs or alcohol during the past 6 months
  • Turned down for transplant due to current or recent substance use
  • Access to telephone

Exclusion Criteria:

  • Psychotic or other unstable serious psychiatric disorders that preclude full, active participation
  • Moderate to severe hepatic encephalopathy
  • Non-English speaking
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00249652

Contacts
Contact: Michelle C Acosta, Ph.D. (212)523-6977 macosta@chpnet.org

Locations
United States, New York
Behavioral Science Research Unit Recruiting
New York, New York, United States, 10025
Contact: Vanessa Constantine, M.A.     212-523-5232     vconstantine@chpnet.org    
Renal & Islet Transplant, Center for Liver Disease Recruiting
New York, New York, United States, 10032
Contact: Vanessa Constantine, M.A.     212-523-5232     vconstantine@chpnet.org    
United States, Virginia
Liver Transplant Program Recruiting
Richmond, Virginia, United States, 23298
Contact: Vanessa Constantine, M.A.     212-523-5232     vconstantine@chpnet.org    
Sponsors and Collaborators
Investigators
Principal Investigator: Deborah Haller St. Luke's Roosevelt Hosp Cntr (New York)
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Publications:
Wagner, C., Haller, D.L., and Olbrisch, M.E. (1996). Journal of Clinical Psychology in Medical Settings, 3, 387-98.

Study ID Numbers: NIDA-15772-1, R01-15772-1
Study First Received: November 3, 2005
Last Updated: November 3, 2005
ClinicalTrials.gov Identifier: NCT00249652  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Renal Insufficiency
Behavior, Addictive
Liver Diseases
Digestive System Diseases
Urologic Diseases
Mental Disorders
Renal Insufficiency, Chronic
Substance-Related Disorders
Kidney Failure, Chronic
Disorders of Environmental Origin
Kidney Diseases
Kidney Failure

ClinicalTrials.gov processed this record on January 14, 2009